Viewing nowRegabacapsule 75 mg (Pregabalin)
Pregabalin 75mg
Hard capsule · Prescription medication
Withus Pharmaceutical Co., Ltd.

MFDS item code 201603420 · Approved 2016.06.14 · Insurance code 660702970
Treatment of peripheral and central neuropathic pain, adjunctive therapy for partial seizures in epilepsy, improvement of fibromyalgia
This drug is used to treat peripheral and central neuropathic pain in adults. It also helps as an adjunct in patients with epilepsy experiencing partial seizures. Moreover, it is used to alleviate the symptoms of fibromyalgia. Overall, it effectively aids in improving nerve-related pain and seizures.
This drug should be taken orally in two divided doses, regardless of food, with a total daily dose. 1. Neuropathic Pain - Peripheral Neuropathic Pain: Starting dose is 150 mg per day. The dose may be increased to 300 mg per day within 3 to 7 days. After that, it may be escalated to a maximum of 600 mg per day at intervals of 7 days. - Central Neuropathic Pain: Starting dose is 150 mg per day. After one week, it may be increased to 300 mg per day.
Administration is not recommended for children under 12 years of age and adolescents aged 12 to 17 due to insufficient safety and efficacy data.
This drug may increase the risk of suicidal thoughts or behaviors, so if there are signs of depression or mood changes during treatment, it is crucial to inform your healthcare provider immediately. It is not advisable to use this drug if there is a hypersensitivity to it or if there are genetic problems such as lactose intolerance. Diabetic patients may experience difficulty controlling blood sugar levels due to weight gain, which could necessitate adjustments in diabetes medication dosages. If symptoms of angioedema occur, the drug should be discontinued immediately and a doctor consulted. Elderly patients should be cautious during initial administration due to the risk of falls caused by dizziness or drowsiness. Blurred vision or changes in vision may occur, and abnormal symptoms should be reported. Abrupt discontinuation of this medication may lead to withdrawal symptoms such as insomnia, headaches, and anxiety, so it should be tapered off per doctor's instructions. Patients with a history of substance abuse may have a higher risk of misuse of this drug, hence it should be administered with caution. Patients with impaired kidney function may require dosage adjustments. Those with cardiac conditions should be cautious when taking this medication. Concomitant use with opioid analgesics could increase the risk of central nervous system depression, so caution is advised. Patients with respiratory or neurological conditions or the elderly may be at risk for severe respiratory depression, so consulting healthcare providers is essential. During early pregnancy, there is a risk of fetal malformations, so women who are pregnant or planning to become pregnant must consult a physician. While breastfeeding, this drug can pass into breast milk; hence, the option of discontinuing breastfeeding or the drug should be considered. There is a risk of accidents due to dizziness and drowsiness when driving or operating machinery, so caution should be exercised until symptoms improve. Severe skin reactions can occur rarely; therefore, if a skin rash or swelling appears, immediate cessation of the drug and a visit to the hospital are required. In case of overdose, confusion, drowsiness, and depressive symptoms may arise, and treatments such as dialysis may be required if necessary. This drug should be kept out of reach of children, and it is advisable not to transfer it to other containers.
Hives, severe swelling (edema), chest tightness, breathing difficulties, cold sweats, pallor, severe rash with fever, blisters, skin peeling, mouth/eye mucosal pain, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice (yellowing of skin or eyes), extreme fatigue, sudden and severe headaches, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urinary issues
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to prevent air or moisture ingress. Additionally, it is best stored at a temperature between 15 degrees and 30 degrees Celsius, avoiding extremes of cold or heat.
Hard capsule with a reddish-brown upper part and a white lower part containing white or pale yellow powder
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 75mg
Hard capsule · Prescription medication
Withus Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.